Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
03/09/2010 | US7674588 Screening using polarization anisotropy in FRET emissions |
03/09/2010 | US7674587 Analyzing the hybridization intensities, by using oligonucleotide probes, which is complementary to target nucleic acid sequence, using principal component analysis; genetic engineering ; rapid efficient method for analyzing polymorphic or biallelic markers |
03/09/2010 | US7674585 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation |
03/09/2010 | US7674583 Alterations in the copy number of the SULT1A1 gene |
03/09/2010 | US7674580 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
03/09/2010 | US7674291 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease |
03/09/2010 | CA2678229A1 Polyanion for improved nucleic acid amplification |
03/09/2010 | CA2402955C Nanoparticles having oligonucleotides attached thereto and uses therefor |
03/09/2010 | CA2302881C Method for quantification of an analyte |
03/09/2010 | CA2172153C Regulation of bcl-2 gene expression |
03/04/2010 | WO2010025340A2 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel |
03/04/2010 | WO2010025177A1 Method and compositions for enhanced anti-tumor effector functioning of t cells |
03/04/2010 | WO2010024852A1 Gene expression profiles associated with lean phenotype and uses thereof |
03/04/2010 | WO2010022443A1 Resistance genes |
03/04/2010 | WO2009111014A3 Gel microdrop composition and method of using the same |
03/04/2010 | WO2009044392A3 Novel sirna structures |
03/04/2010 | US20100058496 Transgenic sweet sorghum with altered lignin composition and process of preparation thereof |
03/04/2010 | US20100058490 Gene Silencing Methods |
03/04/2010 | US20100058489 Nucleic Acid Encoding A Brain Derived Tau Kinase Polypeptide and Methods of Use Thereof |
03/04/2010 | US20100056769 Methods and kit for isolating nucleic acids |
03/04/2010 | US20100056768 Hydroxymethyl substituted rna oligonucleotides and rna complexes |
03/04/2010 | US20100056758 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders |
03/04/2010 | US20100056612 Molecular entities for binding, stabilization and cellular delivery of charged molecules |
03/04/2010 | US20100056611 MN/CA9 Splice Variants |
03/04/2010 | US20100056607 Compositions and their uses directed to hbxip |
03/04/2010 | US20100056475 Cyclodextrin conjugates |
03/04/2010 | US20100056457 Zinc Finger Binding Domains for CNN |
03/04/2010 | US20100056456 Omega Conotoxins |
03/04/2010 | US20100056447 Immunization against chlamydia pneumoniae |
03/04/2010 | US20100056439 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
03/04/2010 | US20100056395 siRNA targeting coatomer protein complex, subunit beta 2 (CPOB2) |
03/04/2010 | US20100055798 Degenerate Nucleobase Analogs |
03/04/2010 | US20100055797 Nano-construction processes and analytical processes |
03/04/2010 | US20100055784 Nucleic acid compounds for inhibiting wnt gene expression and uses thereof |
03/04/2010 | US20100055783 Nucleic acid compounds for inhibiting ras gene expression and uses thereof |
03/04/2010 | US20100055782 Nucleic acid compounds for inhibiting myc gene expression and uses thereof |
03/04/2010 | US20100055780 Targeted nucleotide exchange with propynyl modified oligonucleotides |
03/04/2010 | US20100055778 Mammalian zcytor 11 |
03/04/2010 | US20100055751 Ketoreductase polypeptides and uses thereof |
03/04/2010 | US20100055745 Producing, Cataloging and Classifying Sequence Tags |
03/04/2010 | US20100055739 isolated DNA methyltransferase; catalyzes the methylation of cytosine in the sequence GCNGC |
03/04/2010 | US20100055737 Cyclodipeptide Synthetase and its use for Synthesis of Cyclo(Tyr-Xaa) Cyclodipeptides |
03/04/2010 | US20100055715 Nucleic and amino acid sequences of prokaryotic ubiquitin-like protein and methods of use thereof |
03/04/2010 | US20100055709 Tubulin Mutation Diagnostic |
03/04/2010 | US20100055706 Screening Methods for Transfusion Related Acute Lung Injury (TRALI) |
03/04/2010 | US20100055695 Method For Generating Aptamers with Improved Off-Rates |
03/04/2010 | US20100055692 Method for selection of hop strain, bleeding marker for use in selection of hop strain, and primer set |
03/04/2010 | US20100055682 Procedure and methods for detecting alzheimers's disease |
03/04/2010 | US20100055676 Method of assaying alpha 1, 4-n-acetylglucosamine transferase (alpha 4gnt) mrna |
03/04/2010 | US20100055672 100% sequence identity detection methods for variable genomes |
03/04/2010 | US20100055670 Growth of wild-type hepatitis a virus in cell culture |
03/04/2010 | US20100055669 Generation of Recombinant Genes in Bacteriophages |
03/04/2010 | US20100055506 Newly Discovered Bacterium in the Family Acetobacteraceae |
03/04/2010 | US20100055237 Novel Enzymes for Use In Enzymatic Bleaching of Food Products |
03/04/2010 | US20100055135 Enhancin of hepatitis b virus vaccine and its gene |
03/04/2010 | US20100055130 Staphylococcus aureus proteins and nucleic acids |
03/04/2010 | US20100055127 Procedure For Expressing A Tbpb Protein On The Bacterial Surface Of An Attenuated Oral Live Vaccine As Prototype Of A Meningitis B Vaccine |
03/04/2010 | US20100055124 BRACHYSPIRA PILOSICOLI 72kDa OUTER-MEMBRANE PROTEIN AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
03/04/2010 | US20100055123 Vaccine against burkholderia infections |
03/04/2010 | US20100055122 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
03/04/2010 | US20100055121 Brachyury polypeptides and methods for use |
03/04/2010 | US20100055120 Prostate stem cell antigen (psca) variants and subsequences thereof |
03/04/2010 | US20100055117 Allorestricted peptide-specific t cells |
03/04/2010 | US20100055116 Methods and Compositions for Targeting c-Rel |
03/04/2010 | US20100055109 Post-translationally modified neurotrophins |
03/04/2010 | US20100055108 Drug for treating gastric cancer |
03/04/2010 | US20100055105 Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof |
03/04/2010 | US20100055103 Cross-reactive and bispecific anti-il-17a/f antibodies |
03/04/2010 | US20100055093 Pan-cell surface receptor-specific therapeutics |
03/04/2010 | US20100055085 Hydrolases, nucleic acids encoding them and methods for making and using them |
03/04/2010 | US20100055070 Cytokine-based fusion proteins for treatment of immune disorders |
03/04/2010 | US20100055069 Hpv-18-based papillomavirus vaccines |
03/04/2010 | US20100055034 Human Anti-Folate Receptor Alpha Antibodies and Antibody Fragments for the Radioimmunotherapy of Ovarian Carcinoma |
03/04/2010 | US20100055033 Antibody compositions and methods for treatment of neoplastic disease |
03/04/2010 | CA2740487A1 Resistance genes |
03/04/2010 | CA2735456A1 Method and compositions for enhanced anti-tumor effector functioning of t cells |
03/04/2010 | CA2734519A1 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel |
03/04/2010 | CA2734510A1 Gene expression profiles associated with lean phenotype and uses thereof |
03/03/2010 | EP2159285A2 Methods of amplifying and sequencing nucleic acids |
03/03/2010 | EP2158917A1 P.ariasi polypeptides, P.perniciosus polypeptides and methods of use |
03/03/2010 | EP2158316A2 Gene expression and pain |
03/03/2010 | EP2157979A1 Calcium channel proteins and uses thereof |
03/03/2010 | EP1649065B1 Methods for amplifying polymeric nucleic acids |
03/03/2010 | EP1567662B1 Caged sensors, regulators and compounds and uses thereof |
03/03/2010 | EP1519952B1 Use of aspartic proteases in cosmetics and therapeutics |
03/03/2010 | EP1286682B1 Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury |
03/02/2010 | US7671254 Herbicide resistance gene, compositions and methods |
03/02/2010 | US7671191 By reacting 2-iodoadenosine-5'-N-ethyluronamide with an propynylcyclohexyl ester of given formula; making adenosine receptor agonists; higher yields and less chromatographic purification required |
03/02/2010 | US7671189 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
03/02/2010 | US7671188 Cellulose synthase from pine and methods of use |
03/02/2010 | US7671187 Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same |
03/02/2010 | US7671186 Multimeric hybrid genes encoding the chimeric protein; single recombinant immunogen capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV) |
03/02/2010 | US7671185 Polynucleotide encoding a variant polypeptide of wild-type DsRed or DsRed.T4, a tetrameric variant that has reduced oligomerization relative wild-type DsRed and a fluorescence spectra similar to the fluorescence spectra of the wild-type DsRed |
03/02/2010 | US7671184 Molecular beacons |
03/02/2010 | US7671183 PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use |
03/02/2010 | US7671182 Gene variants of signal transducer and activator of transcription-6 (STAT 6) variants and process of detection the same |
03/02/2010 | US7671181 Protozoan serine/threonine kinase for identifying modulators for use in targeted destruction tumor cells; veterinary medicine |
03/02/2010 | US7671037 Hypoxia induced mitogenic factor |
03/02/2010 | US7670840 Micro-RNA expression abnormalities of pancreatic, endocrine and acinar tumors |
03/02/2010 | US7670829 from a simple carbon source; includes 17 alpha -hydroxypregnenolone, cortisol, cortexolone, 17 alpha -hydroxyprogesterone, and derivatives; genetic engineering |